Pradžia › Glioblastoma
Glioblastoma klinikiniai tyrimai JAV ieško dalyvių
157 tyrimai dėl Glioblastoma ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- New York City, NY30 tyrimai
- Boston, MA28 tyrimai
- Houston, TX25 tyrimai
- Los Angeles, CA23 tyrimai
- Durham, NC20 tyrimai
- San Francisco, CA17 tyrimai
- Washington, DC15 tyrimai
- Rochester, MN15 tyrimai
- Chicago, IL15 tyrimai
- Miami, FL14 tyrimai
- Columbus, OH14 tyrimai
- Jacksonville, FL13 tyrimai
- Aurora, CO12 tyrimai
- St. Louis, MO12 tyrimai
- Atlanta, GA11 tyrimai
- Salt Lake City, UT11 tyrimai
- Philadelphia, PA11 tyrimai
- Baltimore, MD11 tyrimai
- Cleveland, OH11 tyrimai
- Baldwin Park, CA10 tyrimai
- Pittsburgh, PA9 tyrimai
- Birmingham, AL9 tyrimai
- Dallas, TX9 tyrimai
- Nashville, TN9 tyrimai
- Phoenix, AZ8 tyrimai
- Winston-Salem, NC8 tyrimai
- Seattle, WA8 tyrimai
- San Antonio, TX8 tyrimai
- San Diego, CA7 tyrimai
- Edison, NJ7 tyrimai
- Cincinnati, OH6 tyrimai
- Tampa, FL6 tyrimai
- Madison, WI6 tyrimai
- Ann Arbor, MI6 tyrimai
- Lexington, KY5 tyrimai
- Mountain View, CA5 tyrimai
- Queens, NY5 tyrimai
- Omaha, NE5 tyrimai
- Arlington, VA5 tyrimai
- Charlottesville, VA5 tyrimai
Pagal valstiją
- Ajova4 tyrimai
- Alabama9 tyrimai
- Arizona13 tyrimai
- Džordžija12 tyrimai
- Florida30 tyrimai
- Ilinoisas16 tyrimai
- Indianas4 tyrimai
- Kalifornija40 tyrimai
- Kanzasas3 tyrimai
- Kentukis5 tyrimai
- Koloradas14 tyrimai
- Kolumbijos apskritis9 tyrimai
- Konektikutas5 tyrimai
- Masčusetsas29 tyrimai
- Merilendas16 tyrimai
- Minesota19 tyrimai
- Misūris12 tyrimai
- Mičiganas11 tyrimai
- Nebraska5 tyrimai
- New Jersey8 tyrimai
- New York33 tyrimai
- North Carolina26 tyrimai
- Ohio23 tyrimai
- Oklahoma4 tyrimai
- Pennsylvania21 tyrimas
- Rhode Island3 tyrimai
- South Carolina3 tyrimai
- Tennessee10 tyrimai
- Texas33 tyrimai
- Utah11 tyrimai
- Virginia10 tyrimai
- Washington9 tyrimai
- Wisconsin8 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06991101Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT05432804A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT03970447GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07301268GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Renkami dalyviai1 fazė
Amžius nuo 21 iki 70 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06815432The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07285044Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT05902169Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07326566A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT05303467Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07416188Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07145112A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Renkami dalyviai1/2 fazė
Iki 25 metų · Visoms lytims · Atnaujinta 2026-09-25 · NCT04094610Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07195591MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT03896568Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT06047379RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
Renkami dalyviai1 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-23 · NCT06389591OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
Renkami dalyviai2 fazė
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2026-09-23 · NCT06558214Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-22 · NCT06814496A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT05765812Anti-GD2 ADC M3554 in Advanced Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT06641908VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
Renkami dalyviai2 fazė
Amžius nuo 18 iki 98 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07831369REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT07831772Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT04977375ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT07089641A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Renkami dalyviai1 fazė
Amžius 19 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT05698524Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.